Clinical Trial Update: Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SQ109 plus a proton pump inhibitor for Helicobacter pylori infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Proton Pump Inhibitor (proton pump inhibitor)
• SQ109 (SQ109)

Snippet

Sponsor: Sequella, Inc. | Conditions: Helicobacter Pylori Infection | Phase 2 | Status: WITHDRAWN